What You Should Know: - Insilico Medicine, an NYC-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company raises $60 million in Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors. - Insilico is also launching a new state-of-the-art robotics lab and fully robotic biological data factory. They have seen a string of successes thus far in 2022, including the
Read More
AI in Healthcare| AI Impact for Researchers, Clinicians| Policy, News, Analysis, Insights - HIT Consultant
PwC Report: 5 Key Actions for Pharma Companies to Drive Value Growth
What You Should Know: - A new PwC report offers insights into how pharma companies can translate game-changing science into greater returns. - Despite many major therapeutic advancements within the last decade, returns from pharma companies lagged the S&P 500 by about one-third and biotech underperformed by 60 percent. The stock performance divide between the front and back of the pack has been widening. PwC’s analysis showed that in 2021, the five-year
Read More
C2i Genomics, Karkinos Healthcare Partner to Bring AI-Powered Cancer R&D to India
What You Should Know: - C2i Genomics, a cancer intelligence company, announced a strategic partnership with Karkinos Healthcare to develop the first whole-genome sequencing (WGS) MRD test that will further R&D efforts in India. - This partnership will improve diagnostic labs in India by providing them with the ability to validate and monitor the quality of whole-genome cancer screening and minimal residual disease (MRD) products faster. AI-Powered Cancer Detection and Monitoring
Read More
Lightbeam Health Acquires Jvion AI and SDOH Solutions – M&A
What You Should Know: – Lightbeam Health Solutions, Inc., a provider of population health management solutions and services has entered into an asset purchase agreement to acquire the operating assets related to Jvion, Inc., including Jvion’s market-leading AI-enabled prescriptive analytics and social determinants of health (SDoH) solutions. -The strategic partnership combines Lightbeam’s health analytics and outcomes for payers and providers with the Jvion’s predictive technology.
Read More
St. Peter’s Health to Deploy Innovaccer Health Cloud for Optimized Care Management
What You Should Know: St. Peter’s Health, a regional nonprofit healthcare system in Helena, Montana, is moving to the InnovaccerⓇ Health Cloud's Data Activation Platform to support its mission of providing exceptional and compassionate care that treats the whole person and improves the health, wellness, and quality of life for the communities it serves. The health system, an integrated network with more than 100 providers, a 99-bed acute care hospital, physician and urgent care
Read More
Survey: Patient Trust Not a Barrier to AI Medical Imaging Adoption
What You Should Know: According to data from Intelerad, patient trust is not a barrier to AI adoption by medical imaging professionals in the U.S. 64% of respondents either trust or are neutral about a diagnosis solely from AI. The Intelerad study of over 1,000 healthcare consumers across the U.S. uncovers the impact of healthcare’s digital transformation on the healthcare consumer in a post-pandemic world. The results unveil new insights into patient attitudes toward AI. Patient
Read More
Komodo Health Appoints COO, Transcarent, Vytalize Health, RxBenefits, Other Digital Health Appointments
Komodo Health has named Dr. Aswin Chandrakantan as its Chief Operating Officer. Dr. Chandrakantan will also continue to serve as the firm’s Chief Medical Officer, a role he has held since 2016. Dr. Chandrakantan was one of Komodo Health’s earliest employees – following leadership roles at McKinsey and Google – and has played a central role in the company’s rapid-fire growth. RxBenefits appoints Wendy Barnes as its new Chief Executive Officer. Barnes succeeds Bryan Statham, who served as the
Read More
Geisinger & Tempus Create AI Model to Identify Structural Heart Disease
What You Should Know: - Tempus, an $8B precision medicine company, announced a collaborative study with Geisinger focusing on artificial intelligence (AI) model that can accurately identify patients at increased risk of undiagnosed structural heart disease (SHD). The study addresses a critical diagnostic gap – SHD is a progressive disease that affects the valves, walls, chambers, and muscles of the heart, and causes debilitating symptoms or death, yet many patients with the disease go
Read More
RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification
What You Should Know: - RapidAI, a neurovascular and vascular AI-enhanced clinical decision support and patient workflow receives FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast identification and communication of suspected central pulmonary embolism — further strengthening RapidAI’s industry-leading clinical AI platform. - Rapid PE Triage & Notification, in conjunction with Rapid Workflow for PE, will enable care teams to more
Read More
Data-Driven Healthcare Operations Will Transform Outcomes
You don’t need another story urging you to “get to the cloud.” That’s old news for healthcare executives, who’ve long understood the necessity of rebooting the way their organizations operate in the digital era. In a recent McKinsey study, 19 of the 22 healthcare leaders the company interviewed described digital healthcare solutions as “highly relevant” or “relevant” to their businesses. They get it. In fact, digital healthcare has already become the minimum table stakes: 93% of
Read More
